Clinicopathological features and clinical outcomes associated withTP53andBRAFNon-V600mutations in cutaneous melanoma patients-Reference-Cited by-同舟云学术

Clinicopathological features and clinical outcomes associated withTP53andBRAFNon-V600mutations in cutaneous melanoma patients

Published:2016-12-02 Issue:8 Volume:123 Page:1372-1381
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kim Dae Won¹,Haydu Lauren E.²,Joon Aron Y.³,Bassett Roland L.³,Siroy Alan E.⁴,Tetzlaff Michael T.⁴⁵,Routbort Mark J.⁴,Amaria Rodabe N.⁶,Wargo Jennifer A.²⁷,McQuade Jennifer L.⁶,Kemnade Jan⁸,Hwu Patrick⁶,Woodman Scott E.⁶⁹,Roszik Jason⁶⁹,Kim Kevin B.¹⁰,Gershenwald Jeffrey E.²¹¹,Lazar Alexander J.⁴⁵,Davies Michael A.⁵⁶⁹

Affiliation:

1. Department of Medical Oncology; Moffitt Cancer Center; Tampa Florida

2. Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Translational Molecular Pathology; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

7. Department of Genomic Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

8. Department of Internal Medicine; Baylor College of Medicine; Houston Texas

9. Department of Systems Biology; The University of Texas MD Anderson Cancer Center; Houston Texas

10. Melanoma Clinical Research Program, California Pacific Medical Center; San Francisco California

11. Department of Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

University of Texas MD Anderson Cancer Center

Melanoma Research Foundation

AIM at Melanoma

the Miriam and Jim Mulva Research Funds

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. A landscape of driver mutations in melanoma;Hodis;Cell.,2012

2. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma;Siroy;J Invest Dermatol.,2015

3. Clinical correlates of NRAS and BRAF mutations in primary human melanoma;Ellerhorst;Clin Cancer Res.,2011

4. TP53 mutations and survival in squamous-cell carcinoma of the head and neck;Poeta;N Engl J Med.,2007

5. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies;Wattel;Blood.,1994

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of P53 immunostaining in patients with cutaneous melanoma;Biomedical Reports;2023-11-22

2. Unique Spectrum of Activating BRAF Alterations in Prostate Cancer;Clinical Cancer Research;2023-08-22

3. Melanoma and Glioblastoma—Not a Serendipitous Association;Advances in Anatomic Pathology;2023-01-10

4. Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort;JCO Precision Oncology;2022-11

5. Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience;Melanoma Research;2022-08-29